The Impact of Hearing Loss Severity on Balance Intervention Outcomes

October 31, 2024 updated by: University of Arkansas

The goal of this study is to learn about how hearing loss impacts balance intervention outcomes and risk of falling in older adults. The main questions it aims to answer are:

  • How does the evidence-based A Matter of Balance (AMOB) program affect older adults' falls risk and balance-related measures?
  • Is the severity of someone's hearing loss related to their balance intervention (AMOB) outcomes?

Participants will:

  • Complete a hearing and balance test
  • Answer some questions about their background and health history, their thoughts about potential falls and how this impacts them, and their current physical activity level
  • Participate in the A Matter of Balance Program, an evidence-based program that includes group discussion, activities, and exercises to reduce fall risk

Study Overview

Study Type

Interventional

Enrollment (Actual)

29

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Arkansas
      • Little Rock, Arkansas, United States, 72205
        • University of Arkansas for Medical Sciences

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

60 years to 90 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • age of 60 years old or greater
  • absence of any major physical or health condition that would prevent participation in the intervention sessions
  • English speaking

Exclusion Criteria:

  • severe balance disorder diagnosis
  • uncorrected severe vision impairment

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: A Matter of Balance Program
A Matter of Balance is an evidence-based program targeting physical activity and fall prevention for adults 60 years of age and older. This program incorporates active learning discussions and activities along with exercise training to reduce the fear of falling, improve fall efficacy and management, and increase physical activity levels in older adults.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in postural sway from baseline to after completion of AMOB
Time Frame: baseline and within 1 month post training
Postural sway will be assessed using a Balance Tracking Systems pressure plate.
baseline and within 1 month post training

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in balance confidence from baseline to after completion of AMOB
Time Frame: baseline and within 1 month post training
Assessed via the Activity-Specific Balance Confidence Scale. Each item is rated as a percentage reflecting an individual's level of confidence in being able to perform the activity without losing their balance (0% - no confidence, 100% - completely confident). The ratings are then averaged across the 16 items for the total score. A higher score suggests higher self confidence related to balance.
baseline and within 1 month post training
Change in falls risk from baseline to after completion of AMOB
Time Frame: baseline and within 1 month post training
Assessed via Falls Risk Questionnaire. Point values are allocated to each questionnaire item (range: 0-14) with higher scores suggesting a greater falls risk.
baseline and within 1 month post training

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 8, 2023

Primary Completion (Actual)

September 15, 2023

Study Completion (Actual)

September 15, 2023

Study Registration Dates

First Submitted

December 21, 2022

First Submitted That Met QC Criteria

January 8, 2023

First Posted (Actual)

January 12, 2023

Study Record Updates

Last Update Posted (Estimated)

November 4, 2024

Last Update Submitted That Met QC Criteria

October 31, 2024

Last Verified

December 1, 2023

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe